Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

The document lists various dermatology topics, treatments, and diagnostic methods.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Researchers created a skin treatment that could effectively deliver medication into hair follicles.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

A new light-activated treatment speeds up healing of infected wounds without antibiotics.

The hydrogel with silver and ibuprofen promotes wound healing and fights infection.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

COVID-19 infection can significantly cause temporary hair loss.

A new mouse model effectively mimics vitiligo for research and drug testing.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Erlotinib can cause excessive eyelash growth.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.